Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Clinique Ovo clinical trials
Part of The Fertility Partners Inc..
The registry lists 36 studies whose lead sponsor is Clinique Ovo. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 9, 2026.
Keep track of what changes. Save the Clinique Ovo studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- Canada
- 36
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Clinique Ovo.
- Clinique Ovo36 studiesSame company
Something wrong?
Focus areas
Conditions Clinique Ovo leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 36 of 36.
- Menopur And Rekovelle Combination Study Version 2.0RecruitingNCT06997900Phase 2
- Comparison of Follitropin Delta and Follitropin Alfa in Combination With MenotropinCompletedNCT07457684
- Identifying Candidates for Limited Dissection at Microdissection TESE.CompletedNCT07286279
- Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)CompletedNCT06053827
- Effect of Hyperandrogenism on IVF Outcomes in PCOS PatientsTerminatedNCT05555680
- Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic GonadotropinCompletedNCT05873725
- ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)CompletedNCT06128395
- Rescue Progesterone Supplementation During Frozen Embryo TransferSuspendedNCT05555121Phase 2
- Paternal Age and Fetal AneuploidyCompletedNCT05981521
- Timing of Oocyte Retrieval and Micro Testicular Sperm ExtractionCompletedNCT07268235
- Second Ovulation InductionCompletedNCT06502665
- DFI and AneuploidiesCompletedNCT06279715
- Uterine Scratching in Intra-Uterine InseminationCompletedNCT03828786Not applicable
- Correlation of Oxidative Stress and Oocyte Quality in Fertility PreservationCompletedNCT05372549Not applicable
- Ovulation Triggering 2 vs 3 FolliclesCompletedNCT06290921
- Artificial Oocyte ActivationCompletedNCT06290895
- Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)CompletedNCT05866484
- Personalizing Window of Implantation During Frozen Embryo TransferCompletedNCT04840121Not applicable
- Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of StimulationCompletedNCT05737979
- The Paternal Clock: Uncovering the Consequences of Advanced Paternal Age on Sperm DNA FragmentationCompletedNCT05894356
- SMART Protocol vs Antagonist Protocol in IVFCompletedNCT05677828
- Personalized Insemination Treatment StudyCompletedNCT03830723Phase 2
- Impact of Follicular and Blood G-CSF During a Natural Cycle of IVFTerminatedNCT01668225
- Gcsf Injection in Women With Repeated Implantaiton FailureTerminatedNCT02149277Phase 3
- Adjuvant Growth Therapy in in Vitro FertilizationCompletedNCT01715324Phase 4
- AMH and Pregnancy Rate by Age During Stimulate In-Vitro Fertilization ProtocolWithdrawnNCT01762111
- Anti-Mullerian Hormone Levels Before and After an Open MyomectomyTerminatedNCT01723085
- Combining LHu With Ultrasound Monitoring in IUITerminatedNCT01205555Not applicable
- A Trial Evaluating Autologous Endometrial Co-Culture Versus Conventional Medium in the Treatment of InfertilityCompletedNCT01886118Not applicable
- Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21TerminatedNCT01387776
- Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to InsulinWithdrawnNCT01638988Phase 3
- Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro FertilizationWithdrawnNCT01674283Phase 4
- NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization CyclesTerminatedNCT01638767Phase 4
- Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro FertilizationCompletedNCT01762098
- Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization CycleCompletedNCT00971152Phase 3
- Perifollicular Doppler in Natural Cycle In Vitro FertilizationCompletedNCT01668212